Daily Market Brief ยท Wednesday, 17 June 2026

Maple Medical to Acquire Guangzhou Yijie Medical in Major Asset Restructuring Deal

Maple Medical Co., Ltd. announces a significant acquisition plan to enhance its regenerative medicine operations, aiming to integrate key medical assets.

120 material announcements from 67 companies

Today, several companies made significant announcements impacting their operations and market positions. Notably, Maple Medical Co., Ltd. is set to acquire Guangzhou Yijie Medical Technology Co., Ltd. through a combination of share issuance and cash payment, marking a major asset restructuring in the regenerative medicine sector.

Deals & Restructuring

  • Maple Medical Co., Ltd. (301033): Plans to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. through share issuance and cash payment. This transaction is part of a major asset restructuring aimed at expanding its business scope in regenerative medicine.
  • Beijing Shiji Information Technology Co., Ltd. (002153): Issuing shares to acquire assets from Shanghai Yunxin Venture Investment Co., Ltd. and others, with the proposal currently under review.
  • Shenzhen Yinghe Technology Co., Ltd. (300457): Announced the acquisition of 100% equity in Angi (Shanghai) Automation Engineering Co., Ltd. for RMB 204.3484 million, classified as a related party transaction.
  • Gambol Pet Group Co., Ltd. (301498): Plans to acquire intellectual property rights related to the "NPFG brand" from K9 Natural Food Limited for up to RMB 225 million.

Earnings & Performance

  • Jinpu Landscape Co., Ltd. (301098): Announced early redemption of its convertible bonds, with a conversion deadline set for June 22, 2026, urging investors to convert to avoid losses.
  • Zhejiang JW Precision Machinery Co., Ltd. (300984): Reported a change in equity following the withdrawal of Zheng Xiaojun from the acting-in-concert relationship, ceasing his role as controlling shareholder.
  • ST Cuihua Co., Ltd. (002731): Faces potential delisting risk after failing to disclose its annual report and Q1 report by the statutory deadline.

Regulatory & Governance

  • ST Jianyi Co., Ltd. (002789): Out-of-court restructuring application accepted amid financial difficulties, with recommended coordinators for the process.
  • Ningbo Runhe High-Tech Materials Co., Ltd. (300727): Responded to an audit inquiry regarding its convertible bond issuance, addressing concerns about cash flow and financial reporting.
  • Dongjiang Environmental Company Limited (002672): Fulfilled guarantee liability for a loan default by its subsidiary, pursuing recourse against co-guarantors.

Other Notable Developments

  • Walvax Biotechnology Co., Ltd. (300142): Announced successful Phase III clinical trial results for its pneumococcal vaccine in Indonesia, enhancing its market competitiveness.
  • Feilu Co., Ltd. (300665): Continues trading suspension as it plans a change in control by its major shareholder.
  • Shenzhen iN-Cube Automation Co., Ltd. (301312): Reports abnormal stock trading fluctuations, confirming no undisclosed material information.

Investors should monitor these developments closely as they may impact market dynamics and company valuations.

In this brief

This brief is generated by AI from English translations of SZSE filings and may contain errors. It is for information only and is not investment advice.